Changelog
Every addition and correction to the Tracker is logged here, newest first.
-
The Register is now called the Pharma AI Tracker. The address moved from /pharma-ai-register/ to /pharma-ai-tracker/, with permanent redirects from the old address.
-
Nineteen companies were added: Otsuka Holdings, Alnylam Pharmaceuticals, Daiichi Sankyo, Celltrion, Astellas Pharma, Roivant Sciences, Hansoh Pharmaceutical, Insmed, Incyte, BioNTech, Genmab, Innovent Biologics, Viatris, United Therapeutics, Torrent Pharmaceuticals, Shionogi, Jazz Pharmaceuticals, Sobi and PharmaEssentia. A CSL and AWS collaboration entry was added for AI and cloud work in research and clinical development. The Tracker covers 49 companies and 349 sourced entries. Ninety-one new entries were added.
-
Five companies were added: Galderma, Jiangsu Hengrui, Revolution Medicines, BeOne and Sandoz. The Tracker covers 30 companies and 258 sourced entries. Fifteen new entries were added. A new AI drug discovery category covers companies' in-house discovery work, which had been grouped with research partnerships.
-
Pharma AI Tracker launched, covering the top 25 pharma companies by market cap with 243 sourced entries, each linked to a public source. The default view shows 165 entries; research partnerships (78) can be shown with a toggle. The leaderboard, which counts disclosed AI use cases since January 2023, launched alongside it.